Pharmaceuticals Companies By Gross Profit

Gross Profit
Gross ProfitEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
2.86 T
(0.02)
 1.07 
(0.02)
2NVO Novo Nordisk AS
263.33 B
(0.07)
 2.50 
(0.17)
3RDY Dr Reddys Laboratories
193.08 B
(0.05)
 1.44 
(0.07)
4JNJ Johnson Johnson
62.99 B
 0.31 
 0.95 
 0.29 
5MRK Merck Company
50.01 B
 0.17 
 2.00 
 0.35 
6LLY Eli Lilly and
49.34 B
 0.24 
 2.01 
 0.48 
7AZN AstraZeneca PLC ADR
48.4 B
 0.14 
 1.76 
 0.24 
8PFE Pfizer Inc
46.97 B
 0.09 
 1.78 
 0.16 
9NVS Novartis AG ADR
42.98 B
 0.10 
 1.27 
 0.13 
10BMY Bristol Myers Squibb
35.14 B
 0.14 
 1.91 
 0.26 
11SNY Sanofi ADR
33.07 B
 0.05 
 1.53 
 0.07 
12GSK GlaxoSmithKline PLC ADR
23.3 B
 0.19 
 1.77 
 0.33 
13TEVA Teva Pharma Industries
8.4 B
 0.24 
 3.12 
 0.77 
14BHC Bausch Health Companies
7.09 B
 0.03 
 3.26 
 0.08 
15ZTS Zoetis Inc
6.74 B
(0.13)
 2.17 
(0.28)
16VTRS Viatris
5.66 B
 0.18 
 1.97 
 0.35 
17JAZZ Jazz Pharmaceuticals PLC
3.82 B
 0.15 
 3.07 
 0.47 
18OGN Organon Co
3.51 B
(0.11)
 4.15 
(0.46)
19ELAN Elanco Animal Health
2.52 B
 0.11 
 2.10 
 0.23 
20RPRX Royalty Pharma Plc
2.5 B
 0.09 
 1.61 
 0.14 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.